What symptoms indicate an infusion pump malfunction during chemotherapy administration?

What symptoms indicate an infusion pump malfunction during chemotherapy administration?

• A. Headache and dizziness
• B. Pain, swelling, or redness at the infusion site
• C. Fever and chills
• D. Nausea and vomiting

Answer: (B)

An infusion pump malfunction during chemotherapy administration is primarily indicated by symptoms such as pain, swelling, or redness at the infusion site. These symptoms can suggest infiltration, extravasation, or occlusion due to the malfunctioning pump. When the delivery of chemotherapy is interrupted or not functioning properly, the drug may not be administered as intended, leading to localized adverse reactions at the infusion site. In contrast, other symptoms such as headache and dizziness, fever and chills, or nausea and vomiting are not directly tied to pump issues. These may arise from various factors unrelated to the infusion process itself, such as the underlying condition being treated, the side effects of the chemotherapeutic agents, or individual patient responses, rather than a mechanical failure of the infusion equipment. Recognizing issues at the infusion site is crucial for promptly addressing potential complications and ensuring effective treatment delivery.

An infusion pump malfunction during chemotherapy administration is primarily indicated by symptoms such as pain, swelling, or redness at the infusion site. These symptoms can suggest infiltration, extravasation, or occlusion due to the malfunctioning pump. When the delivery of chemotherapy is interrupted or not functioning properly, the drug may not be administered as intended, leading to localized adverse reactions at the infusion site.

In contrast, other symptoms such as headache and dizziness, fever and chills, or nausea and vomiting are not directly tied to pump issues. These may arise from various factors unrelated to the infusion process itself, such as the underlying condition being treated, the side effects of the chemotherapeutic agents, or individual patient responses, rather than a mechanical failure of the infusion equipment. Recognizing issues at the infusion site is crucial for promptly addressing potential complications and ensuring effective treatment delivery.